Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

ARM-X: An Adaptable Mesenchymal Stromal Cell-Based Vaccination Platform Suitable for Solid Tumors

July 2025 Bioprocessing, Cancer, Cell Therapy, Immunomodulation

Sphingomyelinase Licensing of Mesenchymal Stromal Cells Alters Lipid and Protein Metabolites for Immunomodulation

July 2025 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Immunomodulation, Tissue Engineering

Differential Phase Contrast Imaging To Predict MSC Immune Function

July 2025 Bioprocessing, Cell Therapy, Clinical, Immunomodulation

Pluripotent Stem Cell-Derived Extracellular Vesicles for Systemic Immune Modulation in Diabetes Therapy

June 2025 Bioprinting, Bioprocessing, Cell Therapy, Diabetes, Exosomes / Extracellular Vesicles, Immunomodulation, MedTech, Devices, & Materials

An Engineered Adipose Formulation Decreases Hepatic Inflammation and Fibrosis in a Rodent Model of Metabolic Dysfunction-Associated Steatotic Liver Disease

June 2025 Bioprinting, Bioprocessing, Cardiovascular, Cell Therapy, Immunomodulation, Tissue Engineering

Enhancing Mesenchymal Stromal Cell Production of Therapeutic Extracellular Vesicles Using High Throughput Screening and Temporal Presentation of Priming Signals

June 2025 Bioprocessing, Cancer, Cell Therapy, Clinical, Drug Screening, Exosomes / Extracellular Vesicles, Immunomodulation

Let-7b-5p Loaded Mesenchymal Stromal Cell Extracellular Vesicles Reduce Pseudomonas-biofilm Formation and Inflammation in CF Bronchial Epithelial Cells

May 2025 Bioprinting, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Immunomodulation, Lung, Tissue Engineering

Developing An in Vitro Osteochondral Micro-Physiological System for Modeling Cartilage-Bone Crosstalk in Arthritis

May 2025 Bioprinting, Bioprocessing, Cardiovascular, Cell Therapy, Immunomodulation, Orthopedic, Tissue Engineering

Developing a Novel Vascularized Bone Microdevice for Investigating The Post-Stroke Bone Microenvironment

May 2025 Bioprinting, Bioprocessing, Cardiovascular, Exosomes / Extracellular Vesicles, Immunomodulation, MedTech, Devices, & Materials, Orthopedic, Tissue Engineering

Machine Learning Enabled Stem Cell Lipidomics

May 2025 Bioprinting, Bioprocessing, Cancer, Cell Therapy, Immunomodulation, Tissue Engineering
Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocessing
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • Exosomes / Extracellular Vesicles
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email